Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota 55455, United States.
Chem Res Toxicol. 2021 Apr 19;34(4):992-1003. doi: 10.1021/acs.chemrestox.1c00013. Epub 2021 Mar 11.
The tobacco-specific nitrosamines '-nitrosonornicotine (NNN) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) are considered to be two of the most important carcinogens in unburned tobacco and its smoke. They readily cause tumors in laboratory animals and are classified as "carcinogenic to humans" by the International Agency for Research on Cancer. DNA adduct formation by these two carcinogens is believed to play a critical role in tobacco carcinogenesis. Among all the DNA adducts formed by NNN and NNK, 2'-deoxyadenosine (dAdo)-derived adducts have not been fully characterized. In the study reported here, we characterized the formation of -[4-(3-pyridyl)-4-oxo-1-butyl]-2'-deoxyadenosine (-POB-dAdo) and its reduced form -PHB-dAdo formed by NNN 2'-hydroxylation in rat liver and lung DNA. More importantly, we characterized a new dAdo adduct -[4-hydroxy-1-(pyridine-3-yl)butyl]-2'-deoxyadenosine (-HPB-dAdo) formed after NaBHCN or NaBH reduction both in calf thymus DNA reacted with 5'-acetoxy-'-nitrosonornicotine and in rat liver and lung upon treatment with NNN. This adduct was specifically formed by NNN 5'-hydroxylation. Chemical standards of -HPB-dAdo and the corresponding isotopically labeled internal standard [pyridine-]-HPB-dAdo were synthesized using a four-step method. Both NMR and high-resolution mass spectrometry data agreed well with the proposed structure of -HPB-dAdo. The new adduct coeluted with the synthesized internal standard under various LC conditions. Its product ion patterns of MS and MS transitions were also consistent with the proposed fragmentation patterns. Chromatographic resolution of the two diastereomers of -HPB-dAdo was successfully achieved. Quantitation suggested a dose-dependent response of the levels of this new adduct in the liver and lung of rats treated with NNN. However, its level was lower than that of 2-[2-(3-pyridyl)--pyrrolidinyl]-2'-deoxyinosine, a previously reported dGuo adduct that is also formed from NNN 5'-hydroxylation. The identification of -HPB-dAdo in this study leads to new insights pertinent to the mechanism of carcinogenesis by NNN and to the development of biomarkers of NNN metabolic activation.
烟草特异性亚硝胺 '-亚硝基降烟碱(NNN)和 4-(甲基亚硝氨基)-1-(3-吡啶基)-1-丁酮(NNK)被认为是未燃烧烟草及其烟雾中两种最重要的致癌物质。它们很容易在实验动物中引起肿瘤,并被国际癌症研究机构列为“对人类致癌”。这两种致癌物质引起的 DNA 加合物的形成被认为在烟草致癌作用中起关键作用。在 NNN 和 NNK 形成的所有 DNA 加合物中,2'-脱氧腺苷(dAdo)衍生的加合物尚未得到充分表征。在本报告所述的研究中,我们对 NNN 2'-羟化形成的 -[4-(3-吡啶基)-4-氧代-1-丁基]-2'-脱氧腺苷(-POB-dAdo)及其还原形式 -PHB-dAdo 在大鼠肝和肺 DNA 中的形成进行了表征。更重要的是,我们对在小牛胸腺 DNA 中与 5'-乙酰氧基-'-亚硝基降烟碱反应后,通过 NaBHCN 或 NaBH 还原形成的一种新的 dAdo 加合物 -[4-羟基-1-(吡啶-3-基)丁基]-2'-脱氧腺苷(-HPB-dAdo)进行了表征,以及在大鼠肝和肺中用 NNN 处理后形成的 -HPB-dAdo。该加合物是由 NNN 5'-羟化特异性形成的。使用四步合成法合成了 -HPB-dAdo 的化学标准品和相应的同位素标记内标 [吡啶-]-HPB-dAdo。NMR 和高分辨率质谱数据与 -HPB-dAdo 的建议结构非常吻合。在各种 LC 条件下,新的加合物与合成的内标共洗脱。其 MS 和 MS 跃迁的产物离子图谱也与建议的碎裂模式一致。-HPB-dAdo 的两种非对映异构体的色谱分辨率成功实现。定量提示 NNN 处理大鼠肝和肺中该新加合物水平呈剂量依赖性。然而,其水平低于先前报道的 dGuo 加合物 2-[2-(3-吡啶基)--吡咯烷基]-2'-脱氧肌苷,该加合物也是由 NNN 5'-羟化形成的。本研究中 -HPB-dAdo 的鉴定为 NNN 致癌机制和 NNN 代谢激活生物标志物的发展提供了新的见解。